Uncharacterized protein C8orf58 homolog Activators are a diverse set of chemical compounds that interact with various cellular signaling pathways, ultimately leading to an enhancement of the functional activity of Uncharacterized protein C8orf58 homolog. Compounds like Forskolin and IBMX exert their effects by increasing intracellular levels of cyclic nucleotides (cAMP and cGMP respectively), which activate PKA or PKG signaling pathways. Such activation may result in the phosphorylation or conformational change of proteins that interact with or regulate Uncharacterized protein C8orf58 homolog, thereby enhancing its activity. Similarly, PMA, a PKC activator, and Ionomycin, which increases intracellular calcium levels, might modify the phosphorylation state of proteins within pathways where Uncharacterized protein C8orf58 homolog is a component, leading to an increase in its activity. EGCG and Resveratrol also contribute to the activation of Uncharacterized protein C8orf58 homolog but through different mechanisms. EGCG, by inhibiting certain kinases, and Resveratrol, through sirtuin activation, may alter signaling cascades, culminating in the enhancement of Uncharacterized protein C8orf58 homolog activity by reducing competitive or inhibitory interactions within these pathways.
Further, compounds such as Sildenafil, LY294002, and Metformin indirectly augment the activity of Uncharacterized protein C8orf58 homolog through modulation of second messengers and energy-sensing pathways. Sildenafil, by inhibiting PDE5, raises cGMP levels, impacting signaling networks that could intersect with the regulatory mechanisms of Uncharacterized protein C8orf58 homolog. LY294002 and Metformin, through PI3K and AMPK pathway inhibition, respectively, trigger alterations in AKT signaling and energy balance, which may shift cellular processes in a way that favors the activation of Uncharacterized protein C8orf58 homolog. Curcumin's influence on NF-κB and Staurosporine's broad-spectrum kinase inhibitory effects underscore the complexity of cellular signaling and how perturbations in these networks can lead to the selective enhancement of specific proteins like Uncharacterized protein C8orf58 homolog. By influencing various signaling pathways and cellular processes, these activators collectively facilitate the heightened functional activity of Uncharacterized protein C8orf58 homolog without directly impacting its expression levels.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP. This increases their concentrations within the cell, indirectly enhancing PKA or PKG signaling pathways that could upregulate Uncharacterized protein C8orf58 homolog activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC). PKC activation can lead to the phosphorylation of proteins that may be part of the signaling cascade involving Uncharacterized protein C8orf58 homolog, thereby enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases and signaling pathways potentially involved in the regulation and activity of Uncharacterized protein C8orf58 homolog. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain types of kinases, which can lead to the activation of alternative pathways that may enhance the activity of Uncharacterized protein C8orf58 homolog by reducing competitive signaling interactions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to activate sirtuin pathways, which are involved in cellular stress responses. Activation of sirtuins might upregulate cellular pathways, leading to enhanced activity of Uncharacterized protein C8orf58 homolog. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate multiple signaling pathways, including the inhibition of NF-κB. This could lead to altered signaling that enhances the activity of Uncharacterized protein C8orf58 homolog through indirect effects on its regulatory mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to altered AKT signaling. This change might enhance the activity of Uncharacterized protein C8orf58 homolog by affecting downstream signaling pathways that interact with or regulate the protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and metabolism. Inhibition of mTOR can lead to the activation of autophagy and other cellular pathways that might enhance the activity of Uncharacterized protein C8orf58 homolog. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, and while it affects many kinases, it can also preferentially enhance pathways by reducing the phosphorylation of inhibitory sites on proteins involved in pathways that regulate Uncharacterized protein C8orf58 homolog. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK). Activation of AMPK can lead to cellular energy balance shifts that may promote signaling pathways enhancing the activity of Uncharacterized protein C8orf58 homolog. | ||||||